| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/30/2014 | US8921092 System and method for electroporating a sample |
| 12/30/2014 | US8921064 Method for purifying urate oxidase tetramers and octamers |
| 12/30/2014 | US8921058 Prostate tumor markers and methods of use thereof |
| 12/30/2014 | US8920933 Autoxidisable aqueous coating compositions |
| 12/30/2014 | US8920847 Menstrual fluid simulant |
| 12/30/2014 | US8920827 Keratin bioceramic compositions |
| 12/30/2014 | US8920824 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 12/30/2014 | US8920809 Chimera comprising bacterial cytotoxin and methods of using the same |
| 12/30/2014 | US8920808 Cytokine-based fusion proteins for treatment of multiple sclerosis |
| 12/30/2014 | US8920807 Vault complexes for cytokine delivery |
| 12/30/2014 | US8920806 Method of modulating inflammatory response by downregulation of activin |
| 12/30/2014 | US8920802 Methods for the treatment or prevention of systemic sclerosis |
| 12/30/2014 | US8920801 Methods and compositions for increasing arylsulfatase A activity in the CNS |
| 12/30/2014 | US8920800 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| 12/30/2014 | US8920798 Myostatin binding agents, nucleic acids encoding the same, and methods of treatment |
| 12/30/2014 | US8920795 Lyophilized preparation of botulinum toxin |
| 12/30/2014 | US8920794 Method for treating filtration failure after trabeculectomy surgery |
| 12/30/2014 | US8920793 Biodegradable PAOX polymer particle with cationic property |
| 12/30/2014 | US8920792 Injection of collagenase in the treatment of herniated meniscus |
| 12/30/2014 | US8920790 Uses of IL-12 in hematopoiesis |
| 12/30/2014 | US8920777 Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer |
| 12/30/2014 | US8920776 Compositions and methods for the detection diagnosis and therapy of hematological malignancies |
| 12/30/2014 | US8920373 Reduced volume formulation of glatiramer acetate and methods of administration |
| 12/30/2014 | CA2772912C Stable formulation of factor viii |
| 12/30/2014 | CA2674563C Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 12/25/2014 | US20140378658 Neurological therapies |
| 12/25/2014 | US20140378654 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/25/2014 | US20140378527 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 12/25/2014 | US20140378522 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 12/25/2014 | US20140378512 Composition for improving cognition and memory |
| 12/25/2014 | US20140378401 Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations |
| 12/25/2014 | US20140378395 Peptides for the Treatment of Hearing |
| 12/25/2014 | US20140378394 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes |
| 12/25/2014 | US20140378393 Stable Formulations of Linaclotide |
| 12/25/2014 | US20140378392 Uses Of Bremelanotide in Therapy for Female Sexual Dysfunction |
| 12/25/2014 | US20140378383 Methods and compositions for delivery of medicaments to the lungs |
| 12/25/2014 | US20140378381 Stabilized glucagon nanoemulsions |
| 12/25/2014 | US20140378380 Use of unacylated ghrelin, fragments and analogs thereof as antioxidant |
| 12/25/2014 | US20140378379 Combination therapy |
| 12/25/2014 | US20140378376 Dosage Regime for Apolipoprotein Formulations |
| 12/25/2014 | US20140378374 Methods of treatment |
| 12/25/2014 | US20140378373 Rapid-acting insulin formulation comprising a substituted anionic compound |
| 12/25/2014 | US20140378371 Cytokine receptor peptides, compositions thereof and methods thereof |
| 12/25/2014 | US20140378370 Low viscosity highly concentrated suspensions |
| 12/25/2014 | US20140377838 Stabilization of biomolecules using sugar polymers |
| 12/25/2014 | US20140377360 Composition for controlled release of physiologically active substance |
| 12/25/2014 | US20140377353 Pharmaceutical product to induce endogenous exacerbated release of gut hormones pyy and glp1 with therapeutic effect on obesity and type 2 diabetes mellitus |
| 12/25/2014 | US20140377344 Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same |
| 12/25/2014 | US20140377341 Cell lines and their use in encapsulated cell biodelivery |
| 12/25/2014 | US20140377339 Tusc2 therapies |
| 12/25/2014 | US20140377334 In vivo targeting of cells with ligand-conjugated particles |
| 12/25/2014 | US20140377323 Medical device comprising collagen-vi |
| 12/25/2014 | US20140377319 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid |
| 12/25/2014 | US20140377310 Methods to treat allergic conditions |
| 12/25/2014 | US20140377297 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 12/25/2014 | US20140377289 Metallodrugs Having Improved Pharmacological Properties, and Methods of Manufacture and Use Thereof |
| 12/25/2014 | US20140377276 Vascular endothelial cell growth factor antagonists |
| 12/25/2014 | US20140377264 Polypeptide Formulation |
| 12/25/2014 | US20140377259 Methods for inhibiting hiv-1 replication involving the administration of an anti-ccr5 receptor monoclonal antibody and small molecule ccr5 receptor antagonist |
| 12/25/2014 | US20140377257 Combination therapy for b cell disorders |
| 12/25/2014 | US20140377249 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 12/25/2014 | US20140377248 Method for the manufacturing of di-chain proteins for use in humans |
| 12/25/2014 | US20140377246 Enzyme replacement therapy for treating mps vii related bone lesions using a chemically modified enzyme |
| 12/25/2014 | US20140377245 Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use |
| 12/25/2014 | US20140377244 Stable formulations for cns delivery of arylsulfatase a |
| 12/25/2014 | US20140377229 Methods and compositions for tissue regeneration |
| 12/25/2014 | US20140377227 Tissue Transplantation Involving, and Tissues Modified by Decellularization And Recellularization Of Donor Tissues For Minimized Or Obviated Rejection Reactions |
| 12/25/2014 | US20140377226 Tissue Transplantation Involving, and Tissues Modified by Decellularization And Recellularization Of Donor Tissues For Minimized Or Obviated Rejection Reactions |
| 12/25/2014 | US20140377225 Methods of improving bone health and muscle health |
| 12/25/2014 | US20140377224 Method of Treating or Retarding the Development of Blindness |
| 12/25/2014 | US20140377222 Use of interleukin-22 in the treatment of fatty liver disease |
| 12/25/2014 | US20140377221 Biomarkers and combination therapies using oncolytic virus and immunomodulation |
| 12/25/2014 | US20140377218 Hcv immunotherapy |
| 12/25/2014 | US20140377217 Compositions for Preventing Cardiac Arrhythmia |
| 12/25/2014 | US20140377215 Delivery of therapeutic agents by a collagen binding protein |
| 12/25/2014 | US20140377214 Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| 12/25/2014 | US20140377209 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
| 12/25/2014 | US20140377181 Molecules with extended half-lives, compositions and uses thereof |
| 12/25/2014 | US20140377172 Novel Antibody Recognizing a Small Subset of Human Hematopoietic Cells |
| 12/25/2014 | US20140377171 Imaging and Treatment of Neuroendocrine Tumors with Glucose - Dependent Insulinotropic Polypeptide or Analogues or Antagonists Thereof |
| 12/25/2014 | US20140377170 Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| 12/25/2014 | US20140377168 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 12/24/2014 | CN104245739A 乳铁蛋白融合蛋白及其制备方法 Lactoferrin fusion protein and its preparation method |
| 12/24/2014 | CN104245726A 来自人pd1的bc环的免疫调节环状化合物 Bc from human pd1 the cyclic ring of an immunomodulatory compound |
| 12/24/2014 | CN104245725A 用于治疗高雪氏症的口服单位剂型及其用途 For the treatment of Gaucher disease oral unit dosage forms and their use |
| 12/24/2014 | CN104245720A 白细胞介素-3多肽结合物和其用途 Interleukin-3 peptide conjugates and their use |
| 12/24/2014 | CN104244988A 结合治疗活性剂的聚合物、其制备方法以及其用途 Polymer active agent combination therapy, their preparation and their use |
| 12/24/2014 | CN104244981A Glp-1激动剂 Glp-1 agonists |
| 12/24/2014 | CN104244973A 针对口蹄疫(fmd)的基于合成肽的紧急疫苗 For foot and mouth disease (fmd) synthetic peptide-based vaccines for emergency |
| 12/24/2014 | CN104244969A 含有蛋白酶抑制物的组合物、包含前者的组合物和用于产生和使用前者的方法 Composition containing a protease inhibitor, comprising the former compositions and the generation and use of the former method is used |
| 12/24/2014 | CN104244968A Ph20多肽变体、配制物及其应用 Ph20 polypeptide variant, formulation and application |
| 12/24/2014 | CN104244967A 用于抑制和治疗非自身免疫性糖尿病的Hsp60衍生肽和肽类似物 Hsp60 derived peptides for inhibition and treatment of autoimmune diabetes and non-peptide analogs |
| 12/24/2014 | CN104244966A 水母发光蛋白用于减少缺血导致的神经损伤 Aequorin for nerve damage caused by reduction of ischemic |
| 12/24/2014 | CN104244965A 治疗癌症和其它病症的纳米结构 Treatment of cancer and other disorders nanostructures |
| 12/24/2014 | CN104244964A 用于预防或治疗眼科病状的方法和组合物 For preventing or treating ophthalmic pathologies methods and compositions |
| 12/24/2014 | CN104244960A 皮下组织及皮下脂肪组织增加促进用组合物 Increase in subcutaneous tissue and subcutaneous adipose tissue composition for promoting |
| 12/24/2014 | CN104244957A 用于治疗分娩停止的方法 The method of treatment for stopping delivery |
| 12/24/2014 | CN104232718A 铁皮石斛抗肿瘤多肽的制备方法及应用 Dendrobium preparation and application of anti-tumor peptide |
| 12/24/2014 | CN104232714A 龟甲胶多肽的制备方法和制药新用途 Preparation Guijiajiao peptides and pharmaceutical new uses |
| 12/24/2014 | CN104232652A 源于人工合成基因的重组蛋白rLj-RGD4在抗肿瘤药物中的应用 From synthetic gene recombinant protein rLj-RGD4 application of anticancer drugs |